Author/Authors :
Hiroyuki Koshio، نويسنده , , Fukushi Hirayama، نويسنده , , Tsukasa Ishihara، نويسنده , , Hiroyuki Kaizawa، نويسنده , , Takeshi Shigenaga، نويسنده , , Yuta Taniuchi، نويسنده , , Kazuo Sato، نويسنده , , Yumiko Moritani، نويسنده , , Yoshiyuki Iwatsuki، نويسنده , , Toshio Uemura، نويسنده , , Seiji Kaku، نويسنده , , Tomihisa Kawasaki، نويسنده , , Yuzo Matsumoto، نويسنده , , Shuichi Sakamoto، نويسنده , , Shin-ichi Tsukamoto، نويسنده ,
Abstract :
Factor Xa (fXa) is a serine protease, which plays a pivotal role in the coagulation cascade. To improve the oral anticoagulant activity of fXa inhibitors containing a 1,4-diazepane moiety as the P4 part, a prodrug strategy was examined. Among the compounds evaluated in this study, amidoxime prodrugs bearing an ester moiety, such as compounds 21 and 30, showed effective oral anticoagulant activity in mice.
Keywords :
Anticoagulants , Enzyme inhibitors , Amidoxime , Prodrugs , Factor Xa